# A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

> **NCT02591732** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 52178 (actual)

## Conditions studied

- Anticoagulation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02591732
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 52178 (ACTUAL)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02591732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02591732, "A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02591732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*